N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes
N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes
复制标题
DOI:
10.1038/sj.leu.2402485
复制
发表时间:
2002-05-01
期刊:
影响因子:
11.4
通讯作者:
Maurer, BJ
中科院分区:
文献类型:
--
作者:
O'Donnell, PH;Guo, WX;Maurer, BJ
The retinoid, N-(4-hydroxyphenyl)retinamide (4-HPR), mediates p53-independent cytotoxicity and can increase reactive oxygen species and ceramide In solid tumor cell lines. We determined changes In ceramide and cytotoxicity upon treatment with 4-HPR (3-12 muM) In six human acute lymphoblastic leukemia (ALL) cell lines: T cell (MOLT-3, MOLT-4, CEM), pre-B-cell (NALM-6, SMS-SB), and null cell (NALL-1). Exposure to 4-HPR (12 muM) for 96 h caused 4.7 (MOLT-3), 3.5 (MOLT-4), 3.9 (CEM), 2.9 (NALM-6), 4.7 (SMS-SB), AND 4.5 (NALL-1) logs of cell kill. The average 4-HPR concentration that killed 99% of cells (LCgg) for all six lines was 4.8 muM (range: 1.5-8.9 muM). Treatment with 4-HPR (9 muM) for 24 h resulted in an 8.9 +/- 1.0-fold (range: 4.9-15.7-fold) increase of ceramide. Ceramide increase was time- and dose-dependent and abrogated by inhibitors of do novo ceramide synthesis. Concurrent inhibition of ceramide glycosylation/acylation by d,1-threo-(1-phenyl-2-hexadecanoyl-amino-3-morpholino-1-propanol) (PPMP) further increased ceramide levels, and synergistically increased 4-HPR cytotoxicity in four of six ALL cell lines. 4-HPR was minimally cytotoxic to peripheral blood mononuclear cells and a lymphoblastoid cell line, and increased ceramide